Humanized Mice for the Study of Dengue Disease Pathogenesis: Biological Assays.

[1]  S. Yoksan,et al.  Well-balanced immune response and protective efficacy induced by a single dose of live attenuated tetravalent dengue vaccine (KD-382) in monkeys , 2020, Heliyon.

[2]  K. Porter,et al.  Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands , 2020, Tropical Diseases, Travel Medicine and Vaccines.

[3]  I. Kurane,et al.  Non-Human Primate Models of Dengue Virus Infection: A Comparison of Viremia Levels and Antibody Responses during Primary and Secondary Infection among Old World and New World Monkeys , 2020, Pathogens.

[4]  Yong Wei,et al.  A Review on Dengue Vaccine Development , 2020, Vaccines.

[5]  D. Cummings,et al.  Mapping global variation in dengue transmission intensity , 2020, Science Translational Medicine.

[6]  J. Castellanos,et al.  Humanized Mice in Dengue Research: A Comparison with Other Mouse Models , 2020, Vaccines.

[7]  J. Castellanos,et al.  Differential replicative fitness of the four dengue virus serotypes circulating in Colombia in human liver Huh7 cells , 2019, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[8]  Stephen J. Thomas,et al.  A review of Dengvaxia®: development to deployment , 2019, Human vaccines & immunotherapeutics.

[9]  R. Medronho,et al.  Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis , 2019, BMJ Open.

[10]  A. Barrett,et al.  Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. , 2019, The Lancet. Infectious diseases.

[11]  T. Westling,et al.  Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy , 2018, The New England journal of medicine.

[12]  J. Low,et al.  Preclinical Antiviral Testing for Dengue Virus Infection in Mouse Models and Its Association with Clinical Studies. , 2018, ACS infectious diseases.

[13]  Adam G Diehl,et al.  Conserved and species-specific transcription factor co-binding patterns drive divergent gene regulation in human and mouse , 2018, Nucleic acids research.

[14]  E. Ooi,et al.  Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates. , 2017, Antiviral research.

[15]  A. Rothman,et al.  Immune-mediated cytokine storm and its role in severe dengue , 2017, Seminars in Immunopathology.

[16]  Laura J. White,et al.  Utility, Limitations, and Future of Non-Human Primates for Dengue Research and Vaccine Development , 2014, Front. Immunol..

[17]  R. Zellweger,et al.  Mouse Models to Study Dengue Virus Immunology and Pathogenesis , 2014, Front. Immunol..

[18]  H. Margolis,et al.  Analytical and Clinical Performance of the CDC Real Time RT-PCR Assay for Detection and Typing of Dengue Virus , 2013, PLoS neglected tropical diseases.

[19]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[20]  R. Rico-Hesse,et al.  Dengue Virus Tropism in Humanized Mice Recapitulates Human Dengue Fever , 2011, PloS one.

[21]  R. Rico-Hesse,et al.  Humanized Mice Show Clinical Signs of Dengue Fever according to Infecting Virus Genotype , 2009, Journal of Virology.

[22]  F. Guirakhoo,et al.  Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates , 2004, Journal of Virology.

[23]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.